The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Official Title: A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer
Study ID: NCT01031225
Brief Summary: This is a phase 2 study of the HSP90 inhibitor, STA-9090 (ganetespib) in subjects with stage IIIB or IV non-small cell lung cancer (NSCLC).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Arizona Cancer Center; University of Arizona, Tucson, Arizona, United States
Genesis Cancer Center, Hot Springs, Arkansas, United States
City of Hope Medical Center, Duarte, California, United States
UCLA Health System, Santa Monica, California, United States
University of Colorado Cancer Center, Aurora, Colorado, United States
Emory University- Winship Cancer Institute, Atlanta, Georgia, United States
Rush University Medical Center, Chicago, Illinois, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Nevada Cancer Institute, Las Vegas, Nevada, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Piedmont Hematology Oncology Associates, Winston Salem, North Carolina, United States
Oregon Health and Science University, Portland, Oregon, United States
Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Swedish Medical Center, Seattle, Washington, United States